Legend Capital Joins China Renaissance To Lead $293M Investment In Chinese Diagnostics Medical Corporation
August 1, 2018 — 17:07 CST
This Data Is Locked!
This area is available only to Subscribers.
Chinese private equity firm Legend Capital has joined China Renaissance’s healthcare fund to co-lead an investment worth nearly RMB2 billion (US$293 million) in Chinese Diagnostics... [DATA LOCKED]
UNLOCK DATA
Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals